The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Loerop James since 2020.
This trader's CIK number is 1781549.
At the time of last reporting, Loerop James was the Chief Business Officer of Aclaris Therapeutics, Inc.. (stock ticker symbol ACRS).
Also see all insider trading activities at Aclaris Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | ACRS | 0 | $0 | 0 | $0 | 125,400 | $0 |
| 2024 | ACRS | 0 | $0 | 0 | $0 | 18,750 | $0 |
| 2023 | ACRS | 14,705 | $99,964 | 4,267 | $59,272 | 11,250 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | ANIK | 0 | $0 | 0 | $0 | 3,000 | $0 |
| 2020 | ANIK | 0 | $0 | 1,244 | $43,726 | 0 | $0 |
1. Aclaris Therapeutics, Inc. (ACRS)
2. Anika Therapeutics, Inc. (ANIK)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-02-01 | ACRS | Option Ex | 33,500 | .00 | 0 |
| 2024-12-31 | ACRS | Option Ex | 73,750 | .00 | 0 |
| 2025-01-02 | ACRS | Option Ex | 18,150 | .00 | 0 |
| 2024-02-01 | ACRS | Option Ex | 18,750 | .00 | 0 |
| 2023-08-28 | ACRS | Buy | 14,705 | 6.80 | 99,964 |
| 2023-02-08 | ACRS | Sale | 4,267 | 13.89 | 59,272 |
| 2023-02-01 | ACRS | Option Ex | 11,250 | .00 | 0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-07-08 | ANIK | Option Ex | 3,000 | .00 | 0 |
| 2020-07-09 | ANIK | Sale | 1,244 | 35.15 | 43,726 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Loerop James (Chief Business Officer of Aclaris Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.